Stocks and InvestingStocks and Investing
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022

Matt O"Brien Maintained (APYX) at Buy with Increased Target to $12 on, Aug 12th, 2022


Published on 2024-10-27 22:38:56 - WOPRAI, Matt O'Brien
  Print publication without navigation


Matt O"Brien of Piper Sandler, Maintained "Apyx Medical Corporation" (APYX) at Buy with Increased Target from $6 to $12 on, Aug 12th, 2022.

Matt has made no other calls on APYX in the last 4 months.

There is 1 other peer that has a rating on APYX. Out of the 1 peers that are also analyzing APYX, 0 agree with Matt"s Rating of Hold.

This is the rating of the analyst that currently disagrees with Matt;

Kyle Bauser of "Lake Street" Maintained at Strong Buy with Increased Target to $17 on, Tuesday, July 19th, 2022